Domov › Rakovina endometria › Arkansas
Klinické štúdie Rakovina endometria v štáte Arkansas
12 štúdií pre Rakovina endometria hľadá účastníkov v zariadeniach v štáte Arkansas.
Mestá v štáte Arkansas
Oficiálny text štúdie (anglicky)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Prebieha náborFáza 2
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05564377Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Highlands Oncology Group - Fayetteville, Fayetteville
- University of Arkansas for Medical Sciences, Little Rock
- Highlands Oncology Group - Rogers, Rogers
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 2. 10. 2026 · NCT07198074A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of Arkansas Medical School, Little Rock
Prebieha náborFáza 1
Vek 19 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06586957A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
- University of Arkansas Winthrop P. Rockefeller Cancer Institute, Little Rock
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06515613DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Little Rock
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 3. 9. 2026 · NCT06989112A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- University of Arkansas for Medical Sciences, Little Rock
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 21. 8. 2026 · NCT05548296A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07470853Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- University of Arkansas, Little Rock
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT07444814A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 7. 2026 · NCT04657068Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - FTS, Fort Smith
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT07327489Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Michael Birrer, MD, PhD, Little Rock
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 11. 2025 · NCT05997017SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.